Skip to main content
main-content

22.03.2020 | Original Research Article | Ausgabe 9/2020

Clinical Pharmacokinetics 9/2020

An Extension of Janmahasatian’s Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities

Zeitschrift:
Clinical Pharmacokinetics > Ausgabe 9/2020
Autoren:
Jaydeep Sinha, Hesham S. Al-Sallami, Stephen B. Duffull
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s40262-020-00883-1) contains supplementary material, which is available to authorized users.
A comment to this article is available online at https://​doi.​org/​10.​1007/​s40262-020-00905-y.

Abstract

Background

Fat-free mass (FFM)-based dose scaling is increasingly being adopted in clinical pharmacology. Given the complexities with the measurement of FFM in clinical practice, choosing an appropriate equation for FFM is critical for accurate dose scaling. Janmahasatian’s FFM model (FFMJan) has largely remained the preferred choice because of its mechanistic basis and good predictive properties. This model was, however, developed from a largely European cohort and has been shown to give biased predictions of FFM in Indian people.

Objective

The objective of this work was to derive an extended version of the FFMJan model (FFMExt) that accounts for the variation in body composition due to ethnicity, and to demonstrate its application by developing an extended FFM model in an Indian population (FFMExt,Ind).

Methods

The fundamental assumption of FFMJan model development was a linear relationship between bioimpedance and body mass index. In this extension to Janmahasatian’s work, this assumption was extended to allow for potential non-linear relationships. While the original ZJan model parameters were kept fixed, a set of body composition-related parameters \(\varPsi \{ \psi_{1} , \;\psi_{2} , \;\psi_{3} \}\) were incorporated, where \(\psi_{1}\) and \(\psi_{2}\) were the ethnicity factors to the intercept and the linear coefficient, respectively, and \(\psi_{3}\) a non-linear exponent. The model was then applied to data arising from a south Indian population and the \(\varPsi\) parameters were estimated by standard non-linear regression. The data were generated from a reference model for FFM for the Indian population, which was known to provide unbiased estimates for this population.

Results

The parameter estimates (%RSE) of the final FFMExt,Ind model were \(\psi_{1} = 0\) (fixed), \(\psi_{2} = 0.77\) (3.2%) for male patients, 0.70 (3.3%) for female patients, and \(\psi_{3} = 0.72\) (12.4%). The final model predictions were in good agreement with the reference model predictions.

Conclusions

An FFMExt model has been achieved by extending the original FFMJan model assumptions to account for inter-ethnic differences in body composition. The extended model can be applied to any ethnic population by estimating a set of body composition-related parameters \(\varPsi\). This can be performed using bioimpedance data without the need for formal FFM measurements.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt e.Med zum Sonderpreis bestellen!

Zusatzmaterial
Nur für berechtigte Nutzer zugänglich
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 9/2020

Clinical Pharmacokinetics 9/2020 Zur Ausgabe